The World Evidence, Pricing, and Access (EPA) Congress stands as Europe’s premier event in mar...
Read moreObjectives This study delves into the payer perspective of Advanced Therapy Medicinal Products (ATMP...
Read moreThe study explores the complexities of pricing and reimbursement for multi-indication products in th...
Read moreConsultation launched on EU draft Regulation for joint clinical assessments, seeking feedback to imp...
Read moreWe discuss the 2024 VPAG agreement, how it differs from the previous VPAS and whether this will impa...
Read moreWebinar: Discussions on the new Voluntary Scheme for Branded Medicines, Pricing, Access and Growth (...
Read moreANSM establishes a Temporary Scientific Committee to promote biosimilar substitution, enhancing pati...
Read more